Study of carboplatin based combination chemotherapy for good prognosis metastatic malignant teratoma

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN69711558

Enrollment

450

Registered

2001-02-28

Start date

1989-06-01

Completion date

Unknown

Last updated

2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer Cancer Testicular cancer

Interventions

Arm 1 - 4 cycles BEP. Arm 2 - 4 cycles CEB.

Eligibility

Inclusion criteria

Inclusion criteria: Histologically confirmed non-seminomatous germ cell tumour of testis or combined seminoma/teratoma or seminoma with unequivocal raised serum alpha feto protein concentration

Exclusion criteria

Exclusion criteria: Previous chemotherapy.

Design outcomes

Primary

Measure	Time frame
Complete remission on chemotherapy or chemotherapy + surgery. Progression-free survival. Survival, toxicity.	—

Secondary

Measure	Time frame
Not provided at time of registration	—

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026